NASDAQ:CLNN
Clene Stock Jumps After FDA Opens Door to Fast-Track ALS Drug Filing
Clene Inc. is moving to pursue faster U.S. approval for its ALS drug candidate, CNM-Au8. The company cited FDA meeting minutes indicating its current data could support a New Drug Application—the key step toward…
Company hubNASDAQ:CLNN
Clene (CLNN) Stock News & Analysis
Follow the latest Clene (CLNN) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage